Serina Therapeutics SER
NYSE SER
$2.00 -0.01 (-0.48%)
As of: Oct 1, 2026 · 3:14 PM EDT

Serina Therapeutics (SER) Operating Leases (2019 - 2026)

Updated

Serina Therapeutics (SER) posted Operating Leases of $122,000 for Q2 2026, down 34.1% from $185,000 a year earlier.

Analysis

Serina Therapeutics (SER) Operating Leases (2019 - 2026) Analysis & Trends

At the end of FY2025, Serina Therapeutics' Operating Leases came in at $196,000, down 26.9% from FY2024.

  • In prior years, Serina Therapeutics' Operating Leases was $268,000 in FY2024 (-41.9%) and $461,000 in FY2023.
  • The Q2 2026 figure stands as the lowest quarterly Operating Leases in data going back to Q2 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Serina Therapeutics 32.93 Mn -7.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 122,000.00
Dec 31, 2025 196,000.00
Sep 30, 2025 148,000.00
Jun 30, 2025 185,000.00
Mar 31, 2025 227,000.00
Dec 31, 2024 268,000.00
Sep 30, 2024 312,000.00
Jun 30, 2024 362,000.00
Mar 31, 2024 413,000.00
Dec 31, 2023 461,000.00
Sep 30, 2019 142,000.00
Jun 30, 2019 221,000.00
API Access

Serina Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=SER&period=max&api_key=YOUR_API_KEY